Transcript Highlights:

• It's already behind the pharmacy counters. This is not a new thing behind the pharmacy counters.
• Texas Board of Pharmacy, that's a standard Texas Board of Pharmacy. Rules, protocols, etc.
• The Texas Pharmacy Board has already done that.
• The Texas Board of Pharmacy takes care of their pharmacists, the Pharmacy Association takes care of the
• So if the Pharmacy Board of Pharmacy says the person must complete a form verifying their weight, age

Bills: HB25, HB48, HB149, HB254, HB26, HB192, HCR3, HCR4, HCR5, HCR6, HCR8, HCR14, HCR16, HR1, HR2, HR3, HR4, HR6, HR7, HR8, HR9, HR12, HR11, HR13, HR14, HR15, HR16, HR20, HR22, HR23, HR24, HR25, HR26, HR27, HR28, HR29, HR30, HR31, HR32, HR33, HR45, HR48, HR49, HR51, HR52, HR55, HR56, HR57, HR59, HR60, HR61, HR62, HR63, HR64, HR65, HR66, HR70, HR71, HR72, HR74, HCR2, HCR7, HR10, HR21, HR35, HR36, HR37, HR38, HR39, HR40, HR42, HR43, HR44, HR46, HR47, HR50, HR53, HR54, HR67, HR69, HR75, HCR 5, HCR 6, HCR 8, HCR 14, HCR 16, HR 1, HR 3, HR 4, HR 6, HR 7, HR 8, HR 9, HR 12, HR 11, HR 13, HR 14, HR 15, HR 16, HR 20, HR 22, HR 23, HR 24, HR 25, HR 26, HR 27, HR 28, HR 29, HR 30, HR 31, HR 32, HR 33, HR 45, HR 48, HR 49, HR 51, HR 52, HR 55, HR 56, HR 57, HR 59, HR 60, HR 61, HR 62, HR 63, HR 64, HR 65, HR 66, HR 70, HR 71, HR 72, HR 74, HCR 7, HR 10, HR 21, HR 35, HR 36, HR 37, HR 38, HR 39, HR 40, HR 42, HR 43, HR 44, HR 46, HR 47, HR 50, HR 53, HR 54, HR 67, HR 69, HB 25, HB 48, HB 149, HB 254, HB 26, HB 192

Keywords: ivermectin, pharmacist authority, prescription-free, healthcare regulation, patient access, HB 48, Texas alert notification systems, emergency alerts, public warning systems, alert fatigue, notification fatigue, Texas Division of Emergency Management, Department of Public Safety, DPS alerts, emergency management, State of Texas Emergency Assistance Registry, STEAR, disaster notifications, weather alerts, Amber Alert

Transcript Highlights:

• Pharmacies are not just any other corner store or retailer.
• Pharmacies are not just any other corner store or retailer.
• with pharmacies to stop selling tobacco products.
• Association has issued a policy calling on pharmacies and places with pharmacies to stop selling tobacco
• In conclusion, pharmacies and retail locations that contain pharmacies have no business selling tobacco

Summary: The Governmental Organization Committee heard a series of bills focused largely on alcohol licensing, nonprofit funding, tribal grants, public transparency, and tobacco policy. AB 342 (Haney) would allow local governments to create hospitality zones with extended last-call hours on certain days; supporters argued it would boost tourism, nightlife, and major-event readiness, while opponents warned of alcohol-related harms and public safety risks. AB 684 (Patel) would subject the UC Board of Admissions and Relations with Schools to open-meeting requirements, with supporters saying admissions-related changes should be more transparent and allow schools time to adjust. AB 1008 (Addis) would authorize up to 10 new on-sale general licenses in San Luis Obispo County to meet tourism demand, and AB 1039 (Hart) would require state agencies to offer advance payments on new nonprofit grants and contracts, which supporters said would help cash-strapped nonprofits deliver services. AB 221 (Ramos) would revise the Tribal Nation Grant Fund to provide more predictable annual distributions to eligible non-gaming and limited-gaming tribes, and it drew broad support from tribal representatives and others. AB 795 (Jeff Gonzalez) would create a California commission for the nation’s 250th anniversary celebration, with supporters describing it as a privately funded, nonpartisan planning body. AB 828/AB 28 (Mark Gonzalez, as referenced in the transcript) would expand neighborhood-restricted liquor licenses in Los Angeles County to reduce costs and support restaurant recovery, and AB 1246 (Hoover) would increase craft distillers’ direct sales limits and address barrel-storage rules; both were supported as small-business measures. AB 1428 (Ta) would require reporting of all surplus and underutilized state land, and AB 957 (Ortega) would prohibit tobacco sales in pharmacies, with strong public health support. Several bills were voted out on motions to Appropriations, some with amendments, while others were held or left on call until quorum was established; the committee also adopted a consent calendar and left rolls open for absent members on multiple measures.

Transcript Highlights:

• Mokai Community Health Center is currently working with Lai Community Health Center's contract pharmacy
• Our contract was terminated when the Lai Community Health Center went with the Maui-based pharmacy, Maui
• Pharmacy Solutions LLC, also known as Maui Elola Pharmacy.
• Solutions LLC as the Mokai Community Health Center's contract pharmacy effective on Tuesday, April 1
• Health Center's contract Mokai Community Health Center's contract pharmacy<00:42:32.319> effective

Keywords: 910, house, all

Summary: The joint hearing opened with SB 1442, which would update the statute governing the Child and Adolescent Mental Health Division and clarify its role as the state Medicaid provider of intensive mental health services for children and adolescents with serious emotional disturbance. The Department of Health testified in strong support, saying the current statute is outdated and warning against any unfunded mandate because the division relies on federal funding and faces uncertainty about future resources. Written testimony from several organizations also supported the bill. The committees took no immediate action and said they would hold decision-making until later. The hearing then moved to SB 479 on ABLE savings accounts. The Hawaii State Council on Developmental Disabilities and the Hawaii Disability Rights Center supported the measure, arguing that ABLE accounts help people with disabilities save money without losing benefits and that the state needs more outreach and staffing to expand participation. A testifier with a disability said the bill would help people keep Social Security and housing stability. The chair indicated an intention to move the bill forward, and asked about funding; the discussion settled on a requested appropriation of about $75,000 for incentives. Next, SB 1245 on reimbursement of pharmacists drew broad support from the Hawaii Pharmacists Association, rural pharmacies, the Hawaii Primary Care Association, and others, who said the bill would improve access to care, especially on neighbor islands and in rural communities, and help pharmacies participate in 340B-related services. The Insurance Division and HMSA raised concerns about bill language, saying it could be read to cover pharmacists outside an insurer’s network and that the scope of reimbursable services needed clarification; the pharmacists’ association said the bill is intended to apply only to in-network pharmacists and should continue to reference existing scope-of-practice law. The hearing also took up SB 1279, which would allow pharmacists to authorize medications via telehealth under certain circumstances. The State Board of Pharmacy opposed the bill, citing patient safety, a pilot project with reported errors, concerns about controlled substances and unregulated technicians, and the view that in-person pharmacist services are safer and already available on the affected islands. Several pharmacies and health care groups supported the measure as a way to preserve 340B access and improve service on Lānaʻi and Molokaʻi, while some local pharmacies said they already provide in-person service and opposed remote dispensing. No votes were taken in the portion of the hearing provided.

Transcript Highlights:

• Our union contract is the first ever union contract inside of Mass General Hospital, and that is not
• only available at independent pharmacies.
• And as Representative Markey said, they've created a business with health plans, pharmacies, and pharmacy
• So do you get into, pharmacies have agreements with PBMs, correct? Yes. And they sign contracts.
• I have not seen any... ...placement in paying pharmacies.

Keywords: 995, all

Summary: The Joint Committee on Health Care Financing held a public hearing on a broad set of health care bills focused on cost, market oversight, pharmaceutical access, transparency, hospital closures, and pharmacy access. Chairs John Lawn and Cindy Friedman opened by emphasizing recent health care reforms and the need for further action on the drug supply chain, PBMs, private equity, and affordability. The committee heard testimony on several measures, including a Betsy Lehman Center bill to make technical changes and create a permanent trust account for federal and private funding, and bills on hospital profits and fairness, hospital closures and health planning, pharmacy deserts, and health care market oversight and pharmaceutical access. No votes were taken during the hearing. On the hospital profits bill, physicians and labor advocates strongly supported capping hospital CEO compensation at 50 times the lowest-paid worker, requiring greater financial transparency, and directing penalties from high-margin public hospitals into a Medicaid reimbursement fund. Testifiers argued that executive pay is excessive while frontline staff and safety-net services are under strain. Committee members raised concerns about unintended consequences, including whether hospitals might shift workers to contract status or lose executive talent, and whether the bill would actually direct money to the safety net. Supporters responded that the measure is one piece of a larger effort and that the bill’s Medicaid reimbursement provisions would help underserved hospitals. Testimony on market oversight and pharmaceutical access centered on rising health care and drug costs, PBM practices, and the proposal to give the Health Policy Commission authority to set upper payment limits for certain drugs. Consumer advocates, disability advocates, an independent pharmacist, the Attorney General’s office, and others supported stronger oversight, citing premium increases, affordability problems, and the impact of high drug prices on patients and community pharmacies. Pharma and some industry witnesses opposed parts of the bill, warning that upper payment limits could disrupt access, create legal issues, and fail to address the broader supply chain. The committee also heard support for stronger hospital closure notice and public hearing requirements, and for a pharmacy deserts bill aimed at identifying and addressing closures like the one in Roxbury that affected thousands of patients.

Transcript Highlights:

• Schaffner: It's already behind the pharmacy counters.
• So if the pharmacy Board of Pharmacy says the person must complete a form verifying their weight, age
• This is not forcing a pharmacy to sell it OTC.
• , and 85.026, which is the constable's contract.
• Even when they go contract with these Ms.

Bills: HB25, HB48, HB149, HB254, HB26, HB192

Keywords: ivermectin, pharmacist authority, prescription-free, healthcare regulation, patient access, HB 48, Texas alert notification systems, emergency alerts, public warning systems, alert fatigue, notification fatigue, Texas Division of Emergency Management, Department of Public Safety, DPS alerts, emergency management, State of Texas Emergency Assistance Registry, STEAR, disaster notifications, weather alerts, Amber Alert

Transcript Highlights:

• Most rural hospitals lack in-house pharmacies, and they have to contract with local pharmacies to provide
• entities to use multiple contract entities to use multiple contract pharmacies<00:10:22.800>
• pharmacies and they have to contract pharmacies and they have to contract with<00:10:42.920>
• Prescription drugs to pharmacies contracted with a 340B covered entity.
• contracted with a includes pharmacies contracted with a 340b<00:38:00.200> covered<00:38:00.520

Keywords: 00:00 Introductions 02:46 Roll Call 03:35 Discussion on SB 14 46:13 Vote on SB 14 48:07 Discussion on SB 17 50:38 Vote on SB 17, 958, all

Summary: The Senate Standing Committee on Health Services opened with the chair welcoming several new members and outlining session rules: hearings would start and end on time, the committee would limit the number of bills heard each meeting, prioritize bills heard during the interim, and generally avoid using the consent calendar except in extreme circumstances. The committee then briefly considered administrative regulations, which were treated as approved if members had no questions. The main item was Senate Bill 14, a measure addressing the 340B drug discount program. The chair said the bill had already passed the Senate in a prior session and had been heard in interim, so he did not present it again. He described the bill as prohibiting drug manufacturers from discriminating against 340B covered entities by refusing 340B pricing when the same drug is offered at that price in the state. He also said the committee would not debate the federal 340B program itself, but would hear testimony on the bill. Hospital leaders and Kentucky Hospital Association representatives testified in support, arguing that 340B savings are essential to rural hospitals, oncology services, transportation support, chronic care, addiction recovery, and new service lines such as chemotherapy and hepatitis treatment. They said the program helps keep care close to home and that manufacturer restrictions on contract pharmacies have reduced access and cost hospitals millions. Opponents from BIO Kentucky and the National Alliance of Healthcare Purchaser Coalitions argued the bill would expand federal law beyond Congress’s intent, create administrative burdens, and not lower patient out-of-pocket costs. The chair repeatedly pressed opponents to address why Kentucky should be denied the same 340B pricing available in other states. No vote on the bill was taken in the portion provided.

Transcript Highlights:

• pharmacy benefits management from their contracts with Medicaid, managed care organizations.
• With this approach, Medicaid MCOs still get paid for providing pharmacy benefits but must contract with
• Medicaid implemented a transparent payment model where the Medicaid contracts with a single PBM set pharmacy
• Independent pharmacies are often paid below our costs based on essentially non-negotiable contracts with
• PBMs use consolidated market power to force take-it-or-leave-it contract terms on pharmacies, including

Transcript Highlights:

• pharmacies.
• PBMs' own mail-order pharmacies and away from community pharmacies.
• they steer our patients, and they dictate contracts that underpay and force pharmacies to close.
• , our local pharmacies.
• , our local pharmacies.

Summary: The committee heard several health-related measures. SB 27 by Senator Umberg would revise and expand California’s CARE Court by limiting the expansion to people with bipolar I disorder with psychotic features, clarifying the definition of “clinically stabilized,” and narrowing the role of nurse practitioners and physician assistants. Supporters, including behavioral health officials and family members, said the bill would reduce dismissals and better serve people with severe illness; opponents warned the expansion would strain county staffing and housing resources and could undermine voluntary engagement. The bill passed on a do pass motion to the Committee on Public Safety. SB 503 by Senator Weber Pierson would require AI tools used in health care facilities to be identified, monitored, and mitigated for bias when used in clinical decision-making or resource allocation. The author and supporters from Kaiser Permanente and the California Medical Association said the bill would help prevent discriminatory outcomes and improve trust and safety. The committee discussed the need to clarify developer and deployer responsibilities, and the bill passed as amended to Privacy and Consumer Protection. SB 68 by Senator Menjivar would require restaurants to provide written allergen information for the top nine food allergens, with tiered flexibility for smaller establishments. The bill was supported by patients, families, nurses, and allergy organizations, who described severe reactions and the difficulty of relying on verbal disclosures alone. The California Restaurant Association opposed unless amended, seeking broader use of the national model food code and additional liability language. The bill passed as amended to Appropriations. The committee also heard SB 403 by Senator Blakespear, which would remove the sunset from the End of Life Option Act; supporters described the law as a compassionate, well-functioning option for terminally ill patients, while faith-based groups opposed it. The bill passed to Judiciary. Later, SB 41 by Senator Wiener was introduced to rein in pharmacy benefit manager practices that steer patients to mail-order pharmacies and reimburse community pharmacies below cost; community pharmacists and several health organizations testified in support, describing pharmacy closures and patient access problems.

Transcript Highlights:

• Hospitals who use the 340B contract, pharmacies must comply with the federal rules of participation to
• Hospitals who use the 340B contract.<00:00:35.760> Pharmacies<00:00:36.480> must<00:00:
• Pharmacies must comply with contract.
• What the language that passed in 2024 addresses is that the provision of contract pharmacies is allowed
• What the language that passed in 2024 addresses is that the provision of contract pharmacies is allowed

Keywords: 919, house, all

Summary: House File 369 was the main topic, with House authors Rep. Natalie Zeleznikar, Rep. Robert Bierman, and Rep. Dave Baker arguing that the bill would give Minnesota’s 2024 340B law “teeth” by enforcing protections for nonprofit and rural hospitals’ access to the federal drug pricing program. They said the measure costs the state nothing, aligns with similar laws in more than 20 other states, and is needed before adjournment to help hospitals close funding gaps, support services like emergency care, obstetrics, behavioral health, and pharmacy access, and preserve care in remote communities. Several hospital leaders from across greater Minnesota testified that 340B revenue helps keep their facilities viable and that losing it would threaten services and, in some cases, hospital survival. Witnesses described severe financial pressure on rural hospitals, including reimbursement cuts, workforce shortages, inflation, and rising drug costs. Leaders from United Hospital District in Blue Earth, Lakewood Health System in Staples, Ely-Bloomenson Community Hospital, Northshore Health in Grand Marais, Community Memorial Hospital in Cloquet, and Cuyuna Regional Medical Center in Crosby said their hospitals serve as safety-net providers and often operate with thin or negative margins. They emphasized long travel times to other hospitals, seasonal tourism pressures in some areas, and the importance of local emergency, ambulance, inpatient, and specialty services. The Minnesota Hospital Association president also criticized pharmaceutical company messaging and said nonprofit hospitals are working around the clock to maintain access. In response to questions, Zeleznikar said she had considered other enforcement approaches but now supported using the original Senate-passed bill, citing concerns about fraud and the difficulty of alternative enforcement mechanisms. She and hospital leaders distinguished this bill from a separate hospital stabilization-grant proposal, saying both are needed but serve different purposes. No vote was taken at the meeting, and the speakers repeatedly urged House leadership to bring the bill to the floor before session ends.

Transcript Highlights:

• pharmacy benefits management from their contracts with Medicaid managed care organizations."
• out retail pharmacy benefits management from<01:05:27.839> their<01:05:28.079> contracts
• Medicaid MCOs still get paid for providing pharmacy benefits, but must contract with a single PBM and
• PBMs use consolidated market power to force take-it-or-leave-it contract terms on pharmacies, including
• PBMs use consolidated market power to force take-it-or-leave-it contract terms on pharmacies, including

Keywords: 1183, house

Transcript Highlights:

• That subject is pharmacy benefit managers.
• Addressing is slow reimbursement payments from pharmacies to pharmacies from PBMs.
• The first one is that no contract between the Oklahoma Employees Insurance and pharmacy benefit managers
• companies or retail pharmacy chains, special pharmacy businesses, mail order pharmacy businesses, or
• Pharmacies than the rural pharmacies.

Bills: SB1673, SB1500, SB1447, SB1646, SB2007, SB1275, SB2074

Keywords: prosthetics, health insurance, medical necessity, patient rights, insurance liability, pharmacy benefits manager, healthcare providers, claims processing, reimbursement, insurance regulation, employees insurance, contract awarding, certifications, state procurement, insurance plan, mental health, substance use disorders, utilization review, benefit coverage, pharmacy

Transcript Highlights:

• These restrictions often limit health centers to one in-house pharmacy or one contract pharmacy location
• The contract pharmacy restrictions also meant clinic systems can't contract with multiple pharmacies
• More contract pharmacy arrangements would guarantee access in low-income areas, which helps keep pharmacies
• contract pharmacies and each of the different pharmaceuticals.
• contract pharmacies.

Summary: The Assembly Health Committee met on April 22 and took up a special order of bills focused largely on prior authorization and utilization management in health care. The chair framed the discussion as part of a broader legislative effort to reduce delays and barriers to care, especially in behavioral health, chronic disease management, cancer treatment, and rehabilitation services. AB 384 by Assembly Member Connolly would prohibit prior authorization for inpatient mental health or substance use emergency admissions and related physician care; supporters said it would prevent dangerous delays in crisis care, while insurers and health plans warned about fraud, abuse, and ambiguity around residential treatment facilities. The bill was moved on a due pass as amended motion and passed the committee on a party-line style vote, with Republicans largely absent or not voting. The committee then heard AB 510 by Assembly Member Addis, which would require health plans, upon request, to provide a peer reviewer of the same or similar specialty when a treating provider appeals a prior authorization denial or modification. Supporters argued that specialty-matched review would make appeals fairer and more clinically informed; opponents said the requirement was too rigid and that timelines and electronic submission rules needed changes. After discussion about the need for timely, specialty-specific review, the bill was approved on a due pass as amended motion and placed on call. AB 539 by Assembly Member Schiavo would extend prior authorization approvals to one year or the duration of the physician’s prescribed treatment for chronic conditions; supporters cited repeated denials and treatment interruptions, while opponents raised concerns about overbreadth, fraud, and the need for shorter validity periods. The bill was also passed as amended and placed on call. The committee next considered AB 669 by Assembly Member Haney, which would bar concurrent and retrospective review for the first 28 days of medically necessary substance use disorder treatment and limit prior authorization for related outpatient medications. The bill was presented with a powerful personal story from Ryan Matlock’s mother about her son’s death after an insurer cut off treatment early; supporters said the measure would keep patients in care long enough to stabilize, while opponents argued it would reduce oversight and could allow lower-quality or non-evidence-based care. The bill was moved on a due pass as amended motion and placed on call. Finally, AB 512 by Assembly Member Harabedian would shorten prior authorization response times to 24 hours for urgent requests and 48 hours for non-urgent requests; supporters said delays can worsen outcomes, while opponents warned the timelines were unrealistic and could increase administrative burdens and safety issues. The bill was approved as amended and placed on call. AB 574 by Assembly Member Mark Gonzalez was then heard; it would allow up to 12 medically necessary physical therapy sessions for a new episode of care without prior authorization, with supporters emphasizing stroke and neurological recovery and opponents warning of reduced oversight and unnecessary care. The transcript ends during testimony on AB 574, before final action is shown.

Transcript Highlights:

• <02:38:08.800> pharmacies the 340b savings um contract pharmacies the 340b savings um contract
• <02:38:39.920> Pharmacy limitations on contract Pharmacy limitations on contract Pharmacy
• contract Pharmacy profits goes to four contract Pharmacy profits goes to four major<02:58:09.600>
• owned<03:03:23.000> by contract pharmacies that are owned by contract pharmacies that are
• <03:26:14.600> Pharmacy protecting contract Pharmacy protecting contract Pharmacy Arrangements

Keywords: 1191, senate, all

Transcript Highlights:

• At that time, in 1984, the only contract pharmacy that stores in Alabama had was with Alabama... ...stores
• Once the contract was signed, then everybody signed into the network, you began to have a contract with
• Senate Bill 252 regulates the PBM industry, and the Board of Pharmacy regulates the practice of pharmacy
• Previous to owning the pharmacy, I was the last director of pharmacy for the Goodyear Tire and Rubber
• that are specialty pharmacies for them, and so. ...that are specialty pharmacies for them.

Keywords: 923, senate, all

Transcript Highlights:

• Our recent pharmacy benefit manager contract reduced our anticipated cost by 12%.
• contracts on the pharmacy side.
• Some of those policies now limit the covered entities to having only one contracted pharmacy.
• And some of them don't prohibit or don't permit drugs to be shipped to contract pharmacies at all.
• And some of them don't prohibit or don't permit drugs to be shipped to contract pharmacies at all.

Keywords: 1184, house, all

Transcript Highlights:

• legislation retail installment contracts legislation retail installment contracts are<00:03:26.799
• <00:03:42.959> for this is retail installment contracts for this is retail installment contracts
• artificially high prices at the pharmacy artificially high prices at the pharmacy counter<00:19:
• I was able to pull just some Anthem data from our pharmacy retail pharmacy in Campbellville for 2024.
• uh Retail Pharmacy from our uh Pharmacy uh Retail Pharmacy in<00:41:32.640> campbellville<00:

Keywords: Meeting Start: 00:00 Roll Call: 00:10 SB145 Discussion: 02:23 SB145 Vote: 05:13 SB183 Discussion: 06:13 SB183 Vote: 11:37 HB413 Discussion Only: 16:15, 958, all

Summary: The House Standing Committee on Banking and Insurance met with a quorum and first took up Senate Bill 145, sponsored by Sen. David Givens. The bill would update retail installment contract statutes for automobile sales, allowing retailers with installment contracts shorter than 28 days to begin collections after three days instead of waiting for multiple missed payments, and it also harmonizes a related dollar amount in statute from $10 to $15. The committee asked no questions, and the bill received a favorable expression on a roll-call vote. The committee then heard Senate Bill 183 from Sen. Matt Nunn, with testimony from Chris Nolan of the American Property Casualty Insurance Association. The bill would require proxy advisers acting for the State Retirement System to act solely in the financial interest of current and future retirees and to avoid political or social considerations in shareholder voting recommendations. Supporters argued it would keep politics out of public pensions and align proxy advice with fiduciary duties; members praised the bill and noted Kentucky could be among the first states to adopt such a model. The committee approved the bill with favorable expression after a roll-call vote. The committee also reviewed administrative regulation 808 KAR 9:10 from the Department of Financial Institutions, with no vote required. It then took up House Bill 413, a PBM rebate pass-through bill, with testimony from Sarah Wood of the Diabetes Patient Advocacy Coalition. She said the bill would require 85% of negotiated drug rebates to be passed through to patients at the point of sale, lowering out-of-pocket costs, especially for high-rebate drugs such as insulin, while still allowing 15% to remain with plans. She cited examples from other states and argued the bill would benefit about 650,000 Kentuckians. Hope McClaflin of Anthem opposed the bill, saying it would reduce employers’ ability to use rebates to lower premiums, could disproportionately favor high-cost brand-name drug users, and could create significant costs for state and fully insured plans. Members asked questions about other states’ pass-through rates and the effect on premiums, but no final action on House Bill 413 was taken in the portion of the meeting provided.

Transcript Highlights:

• We also partner with our MedImpact pharmacy benefit manager, um, because they look at pharmacy first
• with our with Med impact our Pharmacy with our with Med impact our Pharmacy benefit<00:30:16.840
• > comes<00:30:20.960> to Pharmacy first before Pharmacy comes to Pharmacy first before Pharmacy
• Integrity contract Integrity contract ctor<00:30:29.600> um<00:30:29.720> third<00
• and also the FFS PBM contract.

Keywords: 958, all

Summary: The subcommittee met to review the Department for Medicaid Services’ program integrity work. Commissioner Lisa Lee and Program Integrity Director Jennifer Dudinsky outlined Kentucky Medicaid’s structure, funding, enrollment, and spending, including FMAP rates, the size of the Medicaid and KCHIP populations, the number of providers, and 2024 expenditures. They also described the managed care and fee-for-service populations, noting that managed care serves most members while fee-for-service is concentrated in long-term care and waiver populations. Most of the discussion focused on fraud, waste, abuse prevention, and provider oversight. The department described its provider enrollment and certification checks, revalidation requirements, site reviews, fingerprinting for some high-risk providers, and termination grounds such as false application information, Medicare actions, unreported ownership changes, and abandonment of a provider number. Members asked about nonprofit ownership reporting, MCO fraud oversight, and how the department tracks unusual CPT code utilization, especially in behavioral health. The department said it uses data analytics, audits, policy review, and collaboration with behavioral health staff to monitor those trends. Dudinsky explained the division’s four branches: provider licensing and certification, audits and compliance, recovery, and third-party liability/estate recovery. She described prepayment and postpayment audits, referrals of credible fraud allegations to the Attorney General, monthly meetings with the AG’s office, and coordination with the Office of Inspector General, CMS, HHS OIG, MCOs, and other partners. She also explained payment suspensions, stand-downs during law enforcement investigations, and recovery efforts for overpayments, provider/member fraud, and third-party liability. The department said its recovery and avoidance efforts produced more than $251 million in savings so far in 2025. No votes or formal actions beyond approving the minutes were taken.

Transcript Highlights:

• exempt covered entities from contract exempt covered entities from contract pharmacy<01:19:08.080
• pharmacy restriction sunsets contract pharmacy restriction sunsets that<01:43:17.440> we'll<01
• one contract pharmacy per health center. one contract pharmacy per health center.
• pharmacy in Big clinic's sole contract pharmacy in Big Fork.<01:43:52.719> Our<01:43:52.960><
• pharmacy has no status as a contract pharmacy has no impact<01:48:23.119> on<01:48:23.360>

Keywords: 1187, senate, all

Bills: HB62, HB124, HB182, HB193, HB198, HB203, HB223, HB237, HB469, HB486, HB574, HB779, HB796, HB919, SCR2, SB4, SB36, SB38, SB109, SB152, SB168, SB195, SB216, SB221, SB236, SB404

Keywords: Louisiana Women's Policy, gender equality, policy research, commission membership, women's representation, Domestic Violence, judicial experience, legislation, criminal law, family law, HB182, sexual assault, rape kit, forensic examination, forensic medical exam, sexual assault survivor, sexual assault nurse examiner, SANE, emergency department, hospital staffing

Transcript Highlights:

• There weren't any pharmacies closing. Pharmacies were opening.
• own mail order pharmacy.
• pharmacy, which is one of the largest mail order pharmacies in the country.
• So if there were pharmacies like... ...pharmacies like currently Caremark Specialty Pharmacy, where it's
• When I sold my pharmacies, and I did not want to sell my pharmacies, let's be clear.

Bills: HB4336, HB1818, HB3194, HB3538, HB3682, HB3762, HB3793, HB3930, HB3931, HB3934, HB4124, HB4200, HB4410, HB4457, HB4473, HB3884, HB1912

Keywords: interventional pain management, pain management clinic, chronic pain, acute pain, spinal injections, epidural steroid injection, peripheral nerve block, nerve ablation, spinal cord stimulator, intrathecal infusion pump, endoscopic diskectomy, fluoroscopy, physician supervision, allopathic physician, osteopathic physician, CRNA, certified registered nurse anesthetist, nurse anesthetist, freestanding pain management facility, medical licensure